Predictive Value of Circulating Melanoma Cells (CMCs) in Metastatic Melanoma (MM) Patients Treated With Selective Inhibitors of BRAF
This is an observational prospective pilot study aimed to investigate the association
between changes of total and apoptotic CMC count and disease progression in MM patients
undergoing treatment with selective inhibitors of mutated B-RAF.
Observational Model: Cohort, Time Perspective: Prospective
Change of CMC count during treatment and comparison with CT and PET
Paola Zanovello, Phd
Italy: Ethics Committee